Dermata Therapeutics In (DRMA) PT Lowered to $3 at Maxim Group
Tweet Send to a Friend
Maxim Group analyst Anthony Vendetti lowered the price target on Dermata Therapeutics In (NASDAQ: DRMA) to $3.00 (from $6.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
